- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$171.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$54,375.00
7D
2.9%
1Y
39.8%
Bristol-Myers Squibb
Market Cap: AR$132.1b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$33,500.00
7D
-1.8%
1Y
60.1%
Amgen
Market Cap: US$225.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$14.40
7D
2.6%
1Y
50.6%
Bristol-Myers Squibb
Market Cap: US$130.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$21.97
7D
-2.4%
1Y
44.1%
Bayer
Market Cap: AR$46.9b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$30,820.00
7D
n/a
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$6.75
7D
-3.6%
1Y
n/a
Amgen
Market Cap: AR$225.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$21,780.00
7D
0.6%
1Y
72.2%
GSK
Market Cap: US$72.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$12.87
7D
-6.4%
1Y
40.0%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,230.00
7D
-4.0%
1Y
n/a
Gilead Sciences
Market Cap: US$171.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$34.92
7D
3.2%
1Y
14.3%
GSK
Market Cap: AR$72.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$19,540.00
7D
-6.9%
1Y
54.8%
Tempus AI
Market Cap: AR$9.8b
Operates as a healthcare technology company in the United States.
TEM
AR$6,830.00
7D
-0.9%
1Y
-12.7%
AstraZeneca
Market Cap: AR$177.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$61,550.00
7D
-3.6%
1Y
20.0%
Vertex Pharmaceuticals
Market Cap: AR$130.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$7,860.00
7D
1.0%
1Y
55.0%
Novartis
Market Cap: AR$232.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$59,400.00
7D
-4.1%
1Y
48.0%
Vertex Pharmaceuticals
Market Cap: US$130.9b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.25
7D
2.9%
1Y
36.5%
Novartis
Market Cap: US$232.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$39.45
7D
-2.6%
1Y
34.6%
AstraZeneca
Market Cap: US$177.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$40.60
7D
-2.6%
1Y
4.0%
Tempus AI
Market Cap: US$9.8b
Operates as a healthcare technology company in the United States.
TEMD
US$4.51
7D
1.5%
1Y
-25.3%